Cerebral toxoplasmosis

Case contributed by Ayaz Hidayatov
Diagnosis probable

Presentation

A young male presented with cognitive decline, with mild fever for a week. No previous history of malignancy.

Patient Data

Age: 35 years
Gender: Male
mri
This study is a stack
Sagittal
T1
This study is a stack
Axial
T2
This study is a stack
Axial
FLAIR
This study is a stack
Axial
Gradient Echo
This study is a stack
Axial
DWI
This study is a stack
Coronal
T2
This study is a stack
Axial
T1 C+
This study is a stack
Sagittal
T1 C+
MRS
Download
Info

MR demonstrates right thalamic crescent-shaped, well-defined lesion with perilesional vasogenic oedema. The lesion is hypointense on T1WI, mildly hyperintense on T2WI, with dual rim best seen on T2WI. No calcifications or blood products within the lesion on T2GRE images. Diffusion-weighted images (DWI) shows hypointensity and no restriction. The lesion shows ring enhancement after IV contrast administration.

MR-spectroscopy shows a mild amino-acid peak (0.9 ppm) and severe elevation of the lipid/lactate peak (1.33 ppm). There is also marked depression of the NAA (2.03 ppm) and Creatine (3.02 ppm), no depression of the choline.

Brain MR and MRS findings are most keeping with cerebral toxoplasmosis and less likely brain abscess. 

Post-treatment MRI

mri
This study is a stack
Axial
FLAIR
This study is a stack
Axial
T2
This study is a stack
Coronal
T2
Download
Info

Laboratory and clinical tests reveal a positive HIV test. Tuberculosis markers were negative. The patient treated with broad-spectrum antibiotics.

Follow up MRI after 5 months shows complete resolution of the right thalamic lesion with minimal T2 and FLAIR hyperintense gliotic changes.

Case Discussion

The case illustrates typical findings for cerebral toxoplasmosis. 

How to use cases

You can use Radiopaedia cases in a variety of ways to help you learn and teach.

Creating your own cases is easy.

:

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.